Dr. Mark Lenox with the Texas A&M Institute for Preclinical Studies (TIPS) will give a talk Nov. 6 at 4 p.m. in Room 124 of the H.R. Bright Building on campus.

Lenox’s talk, “Improving Animal and Human Health by Accelerating Drug and Device Development,” is part of the Alliance for Bioinformatics, Computational Biology and Systems Biology (ABCS) Seminar Series.

Abstract
The Texas A&M Institute for Preclinical Studies (TIPS) was created as a conduit through which new ideas in healthcare technology could be implemented and FDA approved. FDA certification of new drugs, devices and therapies requires that all testing be performed according to FDA Good Laboratory Procedures (GLP). Without GLP protocols, even the most promising technologies will not pass FDA certification. Research performed at universities generates a tremendous number of good ideas that never reach the clinic because they are unable to overcome the barriers necessary for FDA approval.

Similar barriers exist for small companies. By providing a framework under which testing protocols can be performed under GLP conditions, TIPS dramatically lowers the cost barriers for university researchers as well as small companies who wish to further develop their ideas and get them ready for an FDA application. In this presentation, we will discuss the origins, capabilities, and structure of TIPS and how it can achieve this goal.

Biography
Dr. Mark Lenox leads the imaging core at the Texas A&M Institute for Preclinical Studies (TIPS). His B.S. degree is in systems engineering from Arizona State, with an M.S.E.E. from Texas A&M and Ph.D. in computer science from the University of Tennessee. Lenox has 20 years of experience in imaging, including 17 years at CTI Molecular Imaging (now part of Siemens Medical) and was part of the engineering team that performed the early development and commercialization of Positron Emission Tomography (PET). He led the High Resolution Research Tomograph program at CTI, and later was director of new product development in the preclinical imaging division. In the preclinical imaging division, he was responsible for the design and implementation of the industry leading Inveon preclinical PET imaging systems. Lenox’s experience includes all levels of design and implementation of imaging systems hardware and software as well as regulatory approvals.

For more information please visit the ABCS Web site at http://abcs.tamu.edu/abcs-seminar.html.

Submitted by Tony Okonski, tonyo@cse.tamu.edu

Popularity: unranked [?]